Global Veterinary Excipients Market Size study, by Application (Biologics, Pharmaceuticals, Medicated Feed Additives), by Animal Type, by Chemical Group (Polymers, Alcohols, Lipids), by Function and Regional Forecasts 2022-2032

Global Veterinary Excipients Market is valued at approximately USD 1.12 billion in 2023 and is anticipated to grow with a moderate yet steady compound annual growth rate of more than 4.10% over the forecast period 2024-2032. Veterinary excipients, long viewed as inert formulation ingredients, are now being redefined as crucial functional contributors to drug delivery, efficacy, stability, and palatability in veterinary pharmaceuticals. As the global demand for animal health therapeutics expands, excipients tailored for diverse species and dosage forms are witnessing significant innovation. Whether facilitating bioavailability in oral medications or enabling controlled-release formulations for livestock and companion animals alike, these supporting compounds are becoming pivotal to modern veterinary drug design. Additionally, with biologics and medicated feed additives gaining traction, the role of excipients in supporting complex formulations is becoming indispensable in driving therapeutic compliance and manufacturing consistency.

What’s accelerating this transformation is the heightened emphasis on precision medicine in veterinary care, a growing interest in biologic-based animal therapeutics, and stringent regulations regarding excipient safety and traceability. The market is being propelled by rising investments from pharmaceutical giants and specialty ingredient manufacturers seeking to diversify into animal health. Moreover, the increasing complexity of veterinary formulations—especially those targeting ruminants, swine, or aquatic animals—demands excipients that perform in species-specific gastrointestinal environments, demonstrating both safety and biofunctionality. However, despite this momentum, the veterinary excipients industry contends with challenges such as limited excipient innovation compared to human health, regulatory ambiguities in emerging economies, and the higher cost burden for reformulated products, particularly in mass-scale livestock applications.

Nevertheless, significant opportunities are emerging for market stakeholders who are willing to invest in cross-disciplinary R&D and collaborative development programs. The integration of novel polymer blends, mucoadhesive agents, and lipid-based carriers is allowing manufacturers to push the boundaries of targeted delivery and sustained release mechanisms in veterinary formulations. Also, the growing adoption of green and biodegradable excipients—driven by rising environmental scrutiny and consumer preference for sustainable products—offers lucrative avenues for innovation. With advanced analytical tools and AI-enabled formulation platforms on the rise, companies can now tailor excipient properties to specific therapeutic needs, animal species, or regional market demands with unprecedented precision.

From a geographic perspective, North America dominates the global veterinary excipients market due to the strong presence of leading veterinary drug manufacturers, well-structured regulatory frameworks, and a matured pet pharmaceutical ecosystem. Europe follows closely, leveraging its robust animal welfare laws and progressive research institutions to foster excipient innovations for both livestock and pets. Asia Pacific is emerging as a high-growth region, spurred by increased veterinary spending, expanding livestock production, and improving access to veterinary healthcare in countries like China, India, and Australia. Latin America and the Middle East & Africa are also gradually embracing advanced excipient technologies, albeit with varying rates of regulatory adoption and infrastructure readiness.

Major market player included in this report are:
• BASF SE
• Croda International PLC
• Evonik Industries AG
• Kerry Group plc
• Associated British Foods plc
• Clariant AG
• Merck KGaA
• Colorcon Inc.
• Roquette Frères
• IMCD N.V.
• Gattefossé
• DFE Pharma
• MEGGLE GmbH & Co. KG
• Spectrum Chemical Mfg. Corp.
• Ashland Global Holdings Inc.

The detailed segments and sub-segment of the market are explained below:

By Application
• Biologics
• Pharmaceuticals
• Medicated Feed Additives

By Animal Type
• (Detailed segmentation to be included as per available data)

By Chemical Group
• Polymers
• Alcohols
• Lipids

By Function
• (Detailed segmentation to be included as per available data)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.